The psoriasis family index: Preliminary results of validation of a quality of life instrument for family members of patients with psoriasis

Dermatology

Volumn 219, Issue 1, 2009, Pages 63-70

  Eghlileb, A M ^a   Basra, M K A ^a   Finlay, A Y ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

'Greater Patient'; Dermatology Life Quality Index; Family members; Partners; Psoriasis Disability Index; Psoriasis Family Index; Psoriasis, secondary impact; Quality of life

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONSTRUCT VALIDITY; CONTENT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISABILITY; EVALUATION; FAMILY; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS FAMILY INDEX; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEXUALITY; TEST RETEST RELIABILITY; VALIDATION STUDY;

FAMILY HEALTH; HUMANS; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 67651094026     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209234     Document Type: Article

References (25)

1. Eghlileb AM, Davies EEG, Finlay AY: Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007; 157: 1245-1250.
2. Basra MKA, Sue-Ho R, Finlay AY: The Family Dermatology Life Quality Index: measuring the secondary impact of skin diseases. Br J Dermatol 2007; 156: 528-538. (Pubitemid 46253923)
3. Basra MKA, Finlay AY: The family impact of skin disease: the Greater Patient concept. Br J Dermatol 2007; 156: 929-937.
4. Richards HL, Fortune DG, Chong SLP, et al: Divergent beliefs about psoriasis are associated with increased psychological distress. J Invest Dermatol 2004; 123: 49-56.
5. Richards HL, Fortune DG, Griffiths CEM: The Greater Patient concept. Br J Dermatol 2008; 158: 176-178.
6. Finlay AY, Khan GK, Luscombe DK, et al: Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 1990; 123: 751-756.
7. Kirby B, Fortune DG, Bhushan M, et al: the Salford Psoriasis Index: a holistic measure of psoriasis. Br J Dermatol 2000; 142: 728-732. (Pubitemid 30226387)
8. Gupta MA, Gupta AK: The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Dermatol Venereol 1995; 75: 240-243.
9. Finlay AY: Skin disease disability: measuring its magnitude. Keio J Med 1998; 47: 131-134.
10. Chamlin SL, Cella D, Frieden IJ, et al: Development of the childhood Atopic Dermatitis Impact Scale: initial validation of a quality of life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005; 125: 1106-1111.
11. Lawson V, Lewis-Jones MS, Finlay AY, et al: The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire. Br J Dermatol 1998; 138: 107-113. (Pubitemid 28077946)
12. Fredriksson T, Pettersson U: Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244. (Pubitemid 8387357)
13. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI), a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
14. Finlay AY, Kelly SE: Psoriasis - An index of disability. Clin Exp Dermatol 1987;12:8-11.
15. Lewis VJ, Finlay AY: Two decades experience of the Psoriasis Disability Index. Dermatology 2005; 210: 261-268.
16. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
17. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-1234
18. Nunnaly JC: Psychometric Theory, ed 2. New York, McGraw-Hill, 1978.
19. Bullinger M, Anderson R, Cell AD: Developing and evaluating cross-cultural instruments: from minimal requirements to optimal models. Qual Life Res 1993; 2: 451-459. (Pubitemid 24035217)
20. Goldbeck L: The impact of newly diagnosed chronic paediatric conditions on parental quality of life. Qual Life Res 2006; 15: 1121-1131. (Pubitemid 44682360)
21. Lohr KN: Assessing health status and quality of life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193-205. (Pubitemid 34553501)
22. Salek MS, Finlay AY: Cyclosporine greatly improves the quality of life in adults with severe atopic dermatitis. Br J Dermatol 1993; 129: 422-430.
23. McKenna KE, Stern RS: The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996; 34: 534-538.
24. Gorsuch RL: Factor Analysis, ed 2. Hillsdale, Erlbaum, 1983.
25. Staab D, Diepgen TL, Fartasch M, et al: Age related, structural educational programmes for the management of atopic dermatitis in children and adolescents: multicentre randomised controlled trial. Br Med J 2006; 332: 933-938. (Pubitemid 44365547)